International Stem Cell ISCO
OTC ISCO
$0.21 -0.05 (-19.23%)
As of: Oct 21, 2026 · 10:19 AM EDT

International Stem Cell (ISCO) EV to CFO (2022 - 2025)

Updated

International Stem Cell's EV to CFO was 15.95 in Q4 2025, compared with -45.36 a year earlier.

Analysis

International Stem Cell (ISCO) EV to CFO (2022 - 2025) Analysis & Trends

From Q4 2022 onward, International Stem Cell has reported EV to CFO for 12 quarters.

  • In earlier years, EV to CFO was -45.36 in FY2024, -1.19 in FY2023 and 2.10 in FY2022.
  • The Q4 2025 figure marks the highest quarterly EV to CFO in data going back to Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.62 Bn 1,103.20 Bn 19.71 Bn
2 Johnson & Johnson 616.94 Bn 535.47 Bn 17.26 Bn
3 AbbVie 501.32 Bn 474.43 Bn 12.70 Bn
4 Merck 367.44 Bn 321.82 Bn 12.21 Bn
5 Novartis Ag 298.20 Bn 262.19 Bn 11.24 Bn
6 Astrazeneca 261.78 Bn 235.47 Bn 12.86 Bn
7 Amgen 235.70 Bn 191.10 Bn 7.24 Bn
8 Gilead Sciences 190.88 Bn 165.07 Bn 6.22 Bn
9 Pfizer 169.72 Bn 116.36 Bn 10.94 Bn
10 International Stem Cell 1.68 Mn -2.29 Mn 1.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 15.95
Jun 30, 2025 3.28
Mar 31, 2025 -1.14
Dec 31, 2024 -45.36
Sep 30, 2024 -3.33
Jun 30, 2024 -15.28
Mar 31, 2024 -1.13
Dec 31, 2023 -1.19
Sep 30, 2023 -0.55
Jun 30, 2023 -0.39
Mar 31, 2023 0.87
Dec 31, 2022 2.10
API Access

International Stem Cell EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=ISCO&period=max&api_key=YOUR_API_KEY